Cart
sales@molnova.com
Aurora Kinase Inhibitor II
CAS No. 331770-21-9
Aurora Kinase Inhibitor II( IUN-70219 )
Catalog No. M24269 CAS No. 331770-21-9
Aurora Kinase Inhibitor II is a cell-permeable anilinoquinazoline that inhibit the activity of Aurora A (IC50 = 0.39 M).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 154 | In Stock |
|
| 5MG | 141 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 381 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 815 | In Stock |
|
| 200MG | 1097 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAurora Kinase Inhibitor II
-
NoteResearch use only, not for human use.
-
Brief DescriptionAurora Kinase Inhibitor II is a cell-permeable anilinoquinazoline that inhibit the activity of Aurora A (IC50 = 0.39 M).
-
DescriptionAurora Kinase Inhibitor II is a cell-permeable anilinoquinazoline that inhibit the activity of Aurora A (IC50 = 0.39 M).
-
In VitroAurora kinase inhibitor-2 (Compound 1) shows excellent levels of Aurora A enzyme inhibition and is also effective in an MCF7 cellular anti-proliferative assay (IC50 value of 1.25 μM).
-
In Vivo——
-
SynonymsIUN-70219
-
PathwayCell Cycle/DNA Damage
-
TargetAurora Kinase
-
RecptorAurora A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number331770-21-9
-
Formula Weight400.43
-
Molecular FormulaC23H20N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(NC1=CC=C(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)C=C1)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Heron N M , Anderson M , Blowers D P , et al. SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors.[J]. Bioorganic & Medicinal Chemistry Letters, 2006, 16(5):1320-1323.
molnova catalog
related products
-
BPR1K653 hydrochlori...
A novel potent Aurora kinase inhibitor that inhibits Aurora-A and Aurora-B with IC50 of 24 nM and 45 nM, respectively.
-
SC-514
SC-514 is an orally active, ATP-competitive IKK-2 inhibitor with IC50 of 3-12 μM, blocks NF-κB-dependent gene expression.
-
Tozasertib
Tozasertib (MK-0457, VX-680) is a highly potent, selective and reversible Aurora kinase inhibitor with Ki of 0.6, 18 and 4.6 nM for Aurora A, B and C, respectively.
